Eton Pharmaceuticals, Inc. (ETON) Stock Analysis

Free AI-powered analysis and research for Eton Pharmaceuticals, Inc. stock

Sector: Healthcare

Full ETON report

Eton Pharmaceuticals, Inc. (ETON) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

📰 Latest Update

ETON Gears Up to Report Q3 Earnings: What Can Investors Expect?

Mon, November 2, 2026 at 4:00 PM UTC 3 min read

Eton Pharmaceuticals (ETON) is set to report its third-quarter 2026 earnings on November 5, with revenue expectations of $42.2 million and earnings of 34 cents per share. The company has seen growth from its commercial products, particularly Increlex and its pediatric offerings, while recent launches and licensing agreements may further support revenue. However, Eton's mixed history of earnings surprises and rising expenses could impact profitability, making investors keen to assess its performance against revised revenue guidance of over $145 million for 2026.

Read full article →

People also watch